EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, TransMedics Group's Enterprise Value is $4,447.2 Mil.
TransMedics Group's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was $-230.1 Mil. Therefore, TransMedics Group's EV-to-FCF for today is -19.33.
The historical rank and industry rank for TransMedics Group's EV-to-FCF or its related term are showing as below:
TMDX'
s EV-to-FCF Range Over the Past 10 Years
Min: -71.38 Med: -16.85 Max: -6.24
Current: -19.33
During the past 8 years, the highest EV-to-FCF of TransMedics Group was -6.24. The lowest was -71.38. And the median was -16.85.
TMDX's EV-to-FCF is ranked worse than 100% of 363
companies
in the Medical Devices & Instruments industry
Industry Median: 27.99
vs TMDX: -19.33
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The historical data trend for TransMedics Group's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of TransMedics Group's EV-to-FCF
For the Medical Devices subindustry, TransMedics Group's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TransMedics Group's EV-to-FCF Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, TransMedics Group's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where TransMedics Group's EV-to-FCF falls into.
TransMedics Group's current Enterprise Value is $4,447.2 Mil.
TransMedics Group's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-230.1 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TransMedics Group (NAS:TMDX) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
TransMedics Group's PE Ratio for today is calculated as:
TransMedics Group's share price for today is $129.98.
TransMedics Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.340.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
TransMedics Group EV-to-FCF Related Terms
Thank you for viewing the detailed overview of TransMedics Group's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
TransMedics Group (TransMedics Group) Business Description
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TMDX has been successfully added to your 